Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas: a Further Plea for Biological Resectability Criteria.

NCT05959213 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Campus Bio-Medico as lead sponsor.

NCT NCT05959213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05959213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas: a Further Plea for Biological Resectability Criteria.
Lead sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Phase
Observational
Overall status
Completed
Start date
January 1, 2000
Completion date
March 1, 2023
Enrollment
2,034 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer